4//SEC Filing
SCHRIER DEREK C 4
Accession 0000921895-22-002282
CIK 0001651561other
Filed
Jul 24, 8:00 PM ET
Accepted
Jul 25, 4:46 PM ET
Size
24.2 KB
Accession
0000921895-22-002282
Insider Transaction Report
Form 4
IC GP, LLC
10% Owner
Transactions
- Purchase
Common Stock
2022-07-21$4.11/sh+290,000$1,191,523→ 6,069,024 total(indirect: See Footnotes) - Purchase
Common Stock
2022-07-21$3.80/sh+179,790$683,454→ 5,348,814 total(indirect: See Footnotes) - Purchase
Common Stock
2022-07-21$3.58/sh+250,000$894,275→ 5,779,024 total(indirect: See Footnotes) - Purchase
Common Stock
2022-07-22$4.06/sh+103,292$419,458→ 6,372,316 total(indirect: See Footnotes) - Purchase
Common Stock
2022-07-22$4.43/sh+90,000$398,997→ 6,462,316 total(indirect: See Footnotes) - Purchase
Common Stock
2022-07-21$4.15/sh+100,000$415,450→ 6,169,024 total(indirect: See Footnotes) - Purchase
Common Stock
2022-07-21$3.97/sh+180,210$715,272→ 5,529,024 total(indirect: See Footnotes) - Purchase
Common Stock
2022-07-22$4.22/sh+100,000$422,090→ 6,269,024 total(indirect: See Footnotes)
Holdings
- 1,282,805(indirect: See Footnotes)
1.75% Convertible Senior Subordinated Notes due 2026
Exp: 2026-02-15→ Common Stock (1,282,805 underlying)
Indaba Capital Management, LLC
10% Owner
Transactions
- Purchase
Common Stock
2022-07-21$3.80/sh+179,790$683,454→ 5,348,814 total(indirect: See Footnotes) - Purchase
Common Stock
2022-07-22$4.22/sh+100,000$422,090→ 6,269,024 total(indirect: See Footnotes) - Purchase
Common Stock
2022-07-21$3.58/sh+250,000$894,275→ 5,779,024 total(indirect: See Footnotes) - Purchase
Common Stock
2022-07-21$3.97/sh+180,210$715,272→ 5,529,024 total(indirect: See Footnotes) - Purchase
Common Stock
2022-07-21$4.11/sh+290,000$1,191,523→ 6,069,024 total(indirect: See Footnotes) - Purchase
Common Stock
2022-07-22$4.06/sh+103,292$419,458→ 6,372,316 total(indirect: See Footnotes) - Purchase
Common Stock
2022-07-21$4.15/sh+100,000$415,450→ 6,169,024 total(indirect: See Footnotes) - Purchase
Common Stock
2022-07-22$4.43/sh+90,000$398,997→ 6,462,316 total(indirect: See Footnotes)
Holdings
- 1,282,805(indirect: See Footnotes)
1.75% Convertible Senior Subordinated Notes due 2026
Exp: 2026-02-15→ Common Stock (1,282,805 underlying)
SCHRIER DEREK C
10% Owner
Transactions
- Purchase
Common Stock
2022-07-21$3.80/sh+179,790$683,454→ 5,348,814 total(indirect: See Footnotes) - Purchase
Common Stock
2022-07-21$3.97/sh+180,210$715,272→ 5,529,024 total(indirect: See Footnotes) - Purchase
Common Stock
2022-07-21$3.58/sh+250,000$894,275→ 5,779,024 total(indirect: See Footnotes) - Purchase
Common Stock
2022-07-21$4.11/sh+290,000$1,191,523→ 6,069,024 total(indirect: See Footnotes) - Purchase
Common Stock
2022-07-21$4.15/sh+100,000$415,450→ 6,169,024 total(indirect: See Footnotes) - Purchase
Common Stock
2022-07-22$4.06/sh+103,292$419,458→ 6,372,316 total(indirect: See Footnotes) - Purchase
Common Stock
2022-07-22$4.22/sh+100,000$422,090→ 6,269,024 total(indirect: See Footnotes) - Purchase
Common Stock
2022-07-22$4.43/sh+90,000$398,997→ 6,462,316 total(indirect: See Footnotes)
Holdings
- 1,282,805(indirect: See Footnotes)
1.75% Convertible Senior Subordinated Notes due 2026
Exp: 2026-02-15→ Common Stock (1,282,805 underlying)
Footnotes (4)
- [F1]This Form 4 is filed jointly by Indaba Capital Management, L.P. (the "Investment Manager"), IC GP, LLC ("IC GP"), and Derek C. Schrier (collectively, the "Reporting Persons"). Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein.
- [F2]Securities are held directly by Indaba Capital Fund, L.P. (the "Fund"). Pursuant to an Investment Management Agreement, the Fund and its general partner have delegated all voting and investment power over the securities directly held by the Fund to the Investment Manager. As a result, each of the Investment Manager, IC GP, as the general partner of Investment Manager, and Mr. Schrier, as Managing Member of IC GP, may be deemed to exercise voting and investment power over such securities. The Fund specifically disclaims beneficial ownership of such securities by virtue of its inability to vote or dispose of such securities as a result of such delegation to the Investment Manager.
- [F3]The Fund directly holds $89,728,000 principal amount of the Issuer's 1.75% Convertible Senior Subordinated Notes due February 15, 2026 (the "Senior Notes"). Subject to conditions described in the indenture governing the Senior Notes, holders of the Senior Notes have the right to convert all or any portion of such Senior Notes into shares of the Issuer's Common Stock at an initial conversion rate of 14.2966 shares of Common Stock per $1,000 principal amount of Senior Notes, subject to adjustment as described in the indenture.
- [F4]As the Issuer has the option, at its sole discretion, to settle conversions of the Senior Notes in cash, shares of Common Stock or a combination of cash and shares of Common Stock, the Reporting Persons are not deemed to be beneficial owners of any shares of Common Stock underlying the Senior Notes for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, as the Reporting Persons do not have the right to acquire such underlying shares of Common Stock.
Documents
Issuer
Tabula Rasa HealthCare, Inc.
CIK 0001651561
Entity typeother
Related Parties
1- filerCIK 0001250078
Filing Metadata
- Form type
- 4
- Filed
- Jul 24, 8:00 PM ET
- Accepted
- Jul 25, 4:46 PM ET
- Size
- 24.2 KB